Neoadjuvant chemotherapy combined with PD-1 inhibitor for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II clinical trial.

被引：0
|
作者：
Sun, Yan [1 ]
Zhao, Dan [1 ]
Zhang, Bin [1 ]
Gao, Shunyu [1 ]
Liu, Wei [1 ]
Xiao, Shaowen [1 ]
Zheng, Baomin [1 ]
Huang, Zhou [1 ]
Bai, Yanhua [1 ]
Wang, Tianxiao [1 ]
Liu, Weixin [1 ]
Xu, Xiaolong [1 ]
Wang, Nan [1 ]
Zhang, Yaru [1 ]
Wan, Meng [1 ]
机构：
[1] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18035
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
    Huang, Yingying
    Sun, Jingjing
    Li, Jun
    Zhu, Dongwang
    Dong, Minjun
    Dou, Shengjin
    Tang, Yong
    Shi, Wentao
    Sun, Qi
    Zhao, Tongchao
    Zhou, Zhihang
    Zhou, Xinyu
    Liu, Ying
    Li, Jiang
    Zhu, Guopei
    Zhang, Ding
    Chen, Yanan
    Zhu, Qi
    Ju, Wutong
    Zhong, Laiping
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (08) : 2220 - 2227
  • [32] Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research
    Ma, J.
    Zhang, J.
    Yang, Y.
    Zheng, D.
    Wang, X.
    Liang, H.
    Zhang, L.
    Xin, Y.
    Ling, X.
    Fang, C.
    Jiang, H.
    Meng, H.
    Zheng, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
  • [33] CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESPRIT): A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Meng, Hongxue
    Zheng, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A436 - A436
  • [34] Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial
    Dan Ou
    Rong Cai
    Wei-Xiang Qi
    Can Cui
    Lu Cao
    Shu-Bei Wang
    Huan Li
    Tao Ma
    Ying Miao
    Cheng Xu
    Gang Cai
    Wei-Guo Cao
    Yun-Sheng Gao
    Jia-Yi Chen
    Hao-Ping Xu
    Cancer Immunology, Immunotherapy, 73 (12)
  • [35] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (vol 10, e004291, 2022)
    Liu, J.
    Yang, Y.
    Liu, Z.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [36] Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open-label, single-arm, phase Ib clinical trial.
    Liu, Zhigang
    Huang, Xiaotao
    Liang, Jun
    Zhong, Guihua
    Liu, Ye
    Liang, Lizhong
    Hong, Haiyu
    Feng, Weineng
    Yang, Shuang
    Zhang, Yaqin
    Peng, Yingpeng
    Liu, Qiandan
    Zhou, Yuling
    Zhang, Zhaoyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in patients with potentially resectable NSCLC: An open-label, single-arm, phase II trial
    Zhu, X.
    Sun, L.
    Song, N.
    Sun, F.
    Yang, J.
    Duan, L.
    Zhao, D.
    He, W.
    Luo, J.
    Zhang, H.
    Wu, C.
    Zhu, Y.
    Zhang, P.
    Jiang, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S942 - S942
  • [38] Neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: Pooled results analysis from two prospective single-arm phase 2 trials
    Gui, Lin
    Xie, Zucheng
    Wang, Xiaolei
    Liu, Shaoyan
    Yi, Junlin
    An, Changming
    Chen, Xinrui
    Shi, Yuankai
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial.
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    Tang, Lin-Quan
    Luo, Meijuan
    Zhao, Chong
    Mo, Hao-Yuan
    Sun, Rui
    Luo, Dong-Hua
    Wang, Lin
    Guo, Shan-Shan
    Xie, Siyi
    Li, Su-Chen
    Liu, Sai-Lan
    Li, Xiao Yun
    Peng, Jing-Yun
    Qiu, Hui-Zhi
    Sun, Xue-Song
    Liu, LiTing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Sintilimab combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: A single-arm, multicenter, phase 2 trial
    Lyu, Jiahua
    Li, Tao
    Liang, Long
    Li, Churong
    Jia, Hongyuan
    Qi, Yunxiang
    Zheng, Xiumei
    Fan, Yu
    Kuang, Hao
    Bai, Hansong
    Zhang, Wanli
    Lu, Guangbing
    Wang, Gan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345